Recombinant GM-CSF: Uses, Benefits, Dosing & Side Effects

Summary of Key Points

Recombinant GM-CSF is a medication that stimulates the production of white blood cells, helping the body fight infections and recover from conditions like neutropenia and bone marrow suppression. GM-CSF therapy is often prescribed for individuals with weakened immune systems due to diseases or treatments such as chemotherapy. Always consult a healthcare provider, such as one of our telemedicine specialists, before starting or adjusting your dose.

Names of Medication

US Brand Name: Leukine

The generic name refers to the active ingredient in the drug. In this case, the generic name is Recombinant GM-CSF.

Pharmacologic Category

Colony Stimulating Factors

Dosing for Recombinant GM-CSF

Recombinant GM-CSF is used to treat a variety of conditions. Below are the recommended doses for adults. Always consult your doctor or one of our telemedicine providers before making any changes to your medication.

1. Neutropenia: 250 mcg/m² daily for 14 days or until neutrophil recovery.
2. Chronic Granulomatous Disease: 3-10 mcg/kg daily, adjusted based on response.
3. Myelodysplastic Syndromes: 250 mcg/m² daily, typically for 14-21 days.
4. Bone Marrow Suppression: 250 mcg/m² daily until neutrophil recovery.
5. Aplastic Anemia: 250 mcg/m² daily, with the duration varying based on response.
6. Cancer-Related Fatigue: 250 mcg/m² daily for 14 days.
7. Sepsis: 250 mcg/m² daily for 14 days.
8. Graft-Versus-Host Disease: 250 mcg/m² daily for 14-21 days.
9. Pulmonary Infections: 250 mcg/m² daily for 14 days.
10. HIV/AIDS-Related Immunodeficiency: 250 mcg/m² daily for 14 days.

Dosage Forms and Strengths

1. Injection: 250 mcg vial (powder for reconstitution)
2. Injection: 500 mcg vial (powder for reconstitution)

Administration Instructions for GM-CSF Therapy

Recombinant GM-CSF is administered via injection, either subcutaneously (under the skin) or intravenously (into a vein). Your healthcare provider will determine the best method for you. If you are administering the medication at home, follow your doctor or nurse’s instructions carefully. Always wash your hands before handling the medication and use a new, sterile needle each time. If you have any questions, our telemedicine providers are available to assist you.

Adverse Reactions and GM-CSF Side Effects

Like all medications, Recombinant GM-CSF may cause side effects. Some are common, while others are rare but more serious. If you experience any side effects, contact your healthcare provider immediately.

Common GM-CSF Side Effects:

1. Fever: A mild increase in body temperature.
2. Bone Pain: Discomfort in the bones, often in the lower back or pelvis.
3. Fatigue: Feeling unusually tired or weak.
4. Injection Site Reactions: Redness, swelling, or pain at the injection site.

Less Common Side Effects:

1. Edema: Swelling in the hands, feet, or other areas of the body.
2. Headache: Mild to moderate head pain.
3. Rash: Skin irritation, redness, or itching.

Serious Side Effects (Rare):

1. Allergic Reactions: Difficulty breathing, swelling of the face, lips, or throat.
2. Shortness of Breath: Trouble breathing or chest tightness.
3. Heart Problems: Irregular heartbeat or chest pain.

Contraindications for Recombinant GM-CSF

A contraindication is a specific situation where a medication should not be used because it may be harmful. For Recombinant GM-CSF, certain conditions may increase the risk of serious side effects or reduce the treatment’s effectiveness. Below are the main contraindications for taking Recombinant GM-CSF:

1. Hypersensitivity to GM-CSF or yeast-derived products: If you are allergic to GM-CSF or yeast-derived components, taking Recombinant GM-CSF could trigger a severe allergic reaction, including rash, difficulty breathing, or swelling.
2. Leukemia or Myeloid Malignancies: Recombinant GM-CSF may stimulate cancer cell growth in patients with certain types of leukemia or myeloid malignancies, as it promotes white blood cell production, which could inadvertently support cancer cell growth.
3. Severe Pulmonary Disease: Patients with severe lung conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, may experience worsening respiratory symptoms due to fluid retention and lung inflammation caused by Recombinant GM-CSF.
4. Heart Failure: Recombinant GM-CSF can cause fluid retention, potentially worsening heart failure symptoms by increasing the heart’s workload.

If you have any of these conditions, discuss them with your healthcare provider before starting Recombinant GM-CSF. Our telemedicine providers are available to help determine if this medication is right for you.

Drug-to-Drug Interactions with GM-CSF Therapy

Recombinant GM-CSF may interact with other medications, affecting its effectiveness or increasing the risk of side effects. Below are some medications that may interact with Recombinant GM-CSF:

1. Corticosteroids (e.g., Prednisone): These drugs can suppress the immune system, potentially reducing the effectiveness of Recombinant GM-CSF in boosting white blood cell production.
2. Immunosuppressants (e.g., Cyclosporine): Since Recombinant GM-CSF stimulates the immune system, using it with immunosuppressants may reduce the effectiveness of both medications.
3. Antineoplastic Agents (e.g., Cisplatin): Some chemotherapy drugs may limit the body’s response to Recombinant GM-CSF, reducing its effectiveness in treating neutropenia or other conditions.
4. Antibiotics (e.g., Ciprofloxacin): Certain antibiotics may increase the risk of side effects, such as inflammation or allergic reactions, when taken with Recombinant GM-CSF.

If you are taking any of these medications, inform your healthcare provider. Our telemedicine team is available to review your medication list and help you avoid potential interactions.

Recombinant GM-CSF in Pregnancy

Is it safe to take Recombinant GM-CSF during pregnancy?

The safety of Recombinant GM-CSF during pregnancy has not been fully established. While animal studies suggest there may be some risks, data on its effects in human pregnancies remain limited. Due to this uncertainty, it is generally recommended to avoid using Recombinant GM-CSF during pregnancy unless the potential benefits clearly outweigh the risks. If you are pregnant or planning to become pregnant, it is essential to consult your healthcare provider to carefully evaluate the risks and benefits of this medication. Our telemedicine providers are available to help guide you through this decision-making process.

Recombinant GM-CSF while Breastfeeding

Is it safe to take Recombinant GM-CSF while breastfeeding?

There is limited information on whether Recombinant GM-CSF passes into breast milk or what effects it might have on a nursing infant. Given the lack of comprehensive data, caution is advised when considering this medication while breastfeeding. It is important to discuss the potential risks and benefits with your healthcare provider before starting or continuing Recombinant GM-CSF while nursing. Our telemedicine team is here to support you in making an informed decision.

Estimated Cost of Recombinant GM-CSF Medication

The cost of a 30-day supply of Recombinant GM-CSF without insurance can vary depending on the pharmacy and location. With a GoodRX coupon, the estimated price typically ranges from $1,500 to $2,500 for a 30-day supply. It is advisable to check with your pharmacy for the most accurate pricing and consider using a discount card or coupon to help reduce the cost.

Possible Alternatives to Recombinant GM-CSF

If Recombinant GM-CSF is not suitable for you, or if you are exploring other treatment options, several alternatives may be available depending on the condition being treated. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers can assist you in exploring these alternatives.

1. Neutropenia: Alternatives may include other colony-stimulating factors such as Filgrastim (Neupogen) or Pegfilgrastim (Neulasta). Adjusting chemotherapy doses or schedules may also help manage neutropenia.
2. Chronic Granulomatous Disease: Antibiotic prophylaxis and antifungal medications are commonly used to prevent infections. In some cases, bone marrow transplantation may be considered.
3. Myelodysplastic Syndromes: Treatment options may include blood transfusions, other growth factors like Epoetin alfa (Procrit), or immune-modifying medications such as Lenalidomide (Revlimid).
4. Bone Marrow Suppression: Alternatives include reducing chemotherapy doses or using other growth factors like Filgrastim or Epoetin alfa to stimulate blood cell production.
5. Aplastic Anemia: Immunosuppressive therapy, blood transfusions, or bone marrow transplants are potential alternatives. Eltrombopag (Promacta) may also be used to stimulate blood cell production.
6. Cancer-Related Fatigue: Lifestyle changes such as regular exercise, adequate sleep, and proper nutrition may help. Medications like Methylphenidate (Ritalin) or Modafinil (Provigil) are sometimes prescribed.
7. Sepsis: Treatment typically involves antibiotics, intravenous fluids, and supportive care in a hospital setting. Recombinant GM-CSF is not commonly used for sepsis, but other immune-modulating therapies may be explored.
8. Graft-Versus-Host Disease: Immunosuppressive medications like Cyclosporine or Tacrolimus are commonly used. In some cases, steroids or other immune-modulating drugs may be necessary.
9. Pulmonary Infections: Depending on the cause of the infection, antibiotics, antivirals, or antifungals are typically used. In some cases, bronchodilators or corticosteroids may be prescribed to reduce lung inflammation.
10. HIV/AIDS-Related Immunodeficiency: Antiretroviral therapy (ART) is the cornerstone of treatment for HIV/AIDS. In some cases, additional medications to boost the immune system or prevent infections may be considered.

Recent Updates on Recombinant GM-CSF Research

Recent studies on Recombinant GM-CSF have focused on its potential role in treating COVID-19-related respiratory failure. Early research suggests that GM-CSF may help reduce lung inflammation and improve outcomes in patients with severe COVID-19 pneumonia. However, more clinical trials are needed to confirm its effectiveness and safety in this context.

Additionally, ongoing research is exploring the use of Recombinant GM-CSF in combination with other immunotherapies for cancer treatment. Preliminary findings suggest it may enhance the immune system’s ability to target and destroy cancer cells, but further studies are required to determine its long-term benefits and risks.

As new research continues to emerge, it is important to stay informed and discuss any potential changes to your treatment with your healthcare provider. Our telemedicine team is available to answer any questions you may have about the latest developments in Recombinant GM-CSF research.

James Kingsley

Learn More